SAB Biotherapeutics (SABS) Preferred Shares (2023 - 2026)
SAB Biotherapeutics' (SABS) quarterly Preferred Shares came in at $59.0 in Q1 2026, up 1080.0% YoY from $5.0 in Q1 2025, and down 7.81% on a QoQ basis from $64.0 in Q4 2025.
SAB Biotherapeutics (SABS) Preferred Shares (2023 - 2026) Analysis & Trends
SAB Biotherapeutics (SABS) has 4 years of Preferred Shares data on file, last reported at $59.0 in Q1 2026.
- Quarterly Preferred Shares rose 1080.0% year-over-year to $59.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $59.0 (up 1080.0% YoY) and the FY2025 annual result came in at $64.0, changed N/A from the prior year.
- Preferred Shares fell to $59.0 in Q1 2026, from $64.0 in the prior quarter.
- In the past five years, Preferred Shares ranged from a high of $64.0 in Q4 2025 to a low of $3.0 in Q3 2025.
- A 4-year average of $17.33 and a median of $5.0 in 2023 frame the typical range for Preferred Shares.
- Annual changes were most pronounced in 2025 — Preferred Shares plunged 40.0% — and 2026, when it surged 1080.0%.
- Tracing SABS's Preferred Shares over 4 years: stood at $5.0 in 2023, then changed by 0.0% to $5.0 in 2024, then surged by 1180.0% to $64.0 in 2025, then slipped by 7.81% to $59.0 in 2026.
- The last three Preferred Shares figures came in at $59.0 (Q1 2026), $64.0 (Q4 2025), and $3.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | SAB Biotherapeutics | 308.92 Mn | 308.92 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59.00 |
| Dec 31, 2025 | 64.00 |
| Sep 30, 2025 | 3.00 |
| Jun 30, 2025 | 5.00 |
| Mar 31, 2025 | 5.00 |
| Sep 30, 2024 | 5.00 |
| Jun 30, 2024 | 5.00 |
| Mar 31, 2024 | 5.00 |
| Dec 31, 2023 | 5.00 |